Pfizer Discontinues Two Phase III Primary Care Projects

Pfizer is halting development of treatments for generalized anxiety disorder and fibromyalgia.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet